Administering an injectable product with glass particulate matter could potentially result in inflammation of a vein, granuloma, and blockage of blood vessels or life-threatening blood clot events.
Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP ABBOJECT® Glass Syringe, 5 mEq/10 mL; 8.4% Sodium Bicarbonate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results